<DOC>
	<DOCNO>NCT01181440</DOCNO>
	<brief_summary>This study randomly assign patient plantar diabetic foot ulcer receive conventional therapy ( debridement , infection control , saline-moistened gauze dressing , standardize off-weighting ) alone conventional therapy plus Dermagraft ( R ) . Dermagraft device contain live human fibroblast grow absorbable polyglactin ( Vicryl ) mesh . Patients evaluate weekly Week 12 , every four week Week 32 .</brief_summary>
	<brief_title>Dermagraft ( R ) Treatment Patients With Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patient 18 year old old . Patient current diagnosis NIDDM IDDM . Patient 's ulcer present minimum two week current Investigator 's care The study ulcer heal &lt; 50 % size two week lead randomization The study ulcer plantar surface forefoot The ulcer &gt; /= 1.0 cm2 Day 0 ( day randomization ) . The ulcer extend dermis subcutaneous tissue without exposure muscle , tendon , bone , joint capsule . The ulcer free necrotic debris clinical infection comprise healthy , vascular tissue suitable skin grafting . The patient 's AnkleArn Index Doppler &gt; 0.1 There adequate circulation foot allow heal . The patient 's diabetes control determine Investigator . Female patient capable bearing child must test negative pregnancy must use acceptable mean birth control . Patient caregiver willing participate clinical study comply followup regimen . Patient his/her legal representative read sign Institutional Review Board ( IRB ) approve Informed Consent form . Patient clinical evidence gangrene part affect foot . The ulcer Charcot deformity . The ulcer nondiabetic etiology . The ulcer tunnel sinus tract completely debrided . The patient 's diabetes uncontrolled could interfere completion study . There medical condition ( ) Investigator 's opinion make patient inappropriate candidate study . Patient has/had malignant disease remission 5 year . Patient acute chronic hepatitis , cirrhosis , serum albumin &lt; 2.0 gms/dL , alkaline phosphatase LDH twice upper limit normal range . Patient receive oral parenteral corticosteroid , immunosuppressive cytotoxic agent , anticipated require agent course study . Patient Acquired Immunodeficiency Syndrome ( AIDS ) infect Human Immunodeficiency Virus ( HIV ) . Patient participate another study utilize investigational drug device within previous 30 day . The ulcer cellulitis , osteomyelitis , clinical evidence infection . Patient condition ( ) seriously compromise ability complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Diabetic foot ulcer</keyword>
	<keyword>Randomized trial</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Dermagraft</keyword>
	<keyword>Conventional care</keyword>
</DOC>